Brookdale Senior Living, Inc.
BKD
$12.98
-4.28%
Brookdale Senior Living operates senior living communities across the United States, focusing on independent living, assisted living, and memory care. It is a major national operator in the senior housing industry, leveraging its scale and diversified service offerings.
BKD
Brookdale Senior Living, Inc.
$12.98
Investment Opinion: Should I buy BKD Today?
Based on a synthesis of the data, the objective assessment for BKD is a Hold. The stock is not a clear 'Buy' due to its persistent unprofitability, high leverage, and recent price consolidation. However, it is also not a 'Sell' given its strong long-term momentum, positive analyst upgrades, and attractive valuation on a sales basis. The investment thesis is speculative and contingent on the company's ability to achieve the analyst-forecasted profitability (estimated EPS of $0.07).
Sign up to view all
BKD 12-Month Price Forecast
The outlook is balanced with high uncertainty. The base case of range-bound trading is most probable, but the stock has binary potential based on its ability to hit profitability targets, justifying a neutral stance with medium confidence.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brookdale Senior Living, Inc.'s 12-month outlook, with a consensus price target around $16.87 and implied upside of +30.0% versus the current price.
Average Target
$16.87
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$10 - $17
Analyst target range
Wall Street analyst coverage is limited, with only three analysts providing estimates. The consensus estimated EPS for the next period is $0.07, with revenue estimated at approximately $3.12 billion. Recent institutional ratings have been positive, including upgrades to 'Buy' and 'Overweight' from B of A Securities and Barclays, respectively, in early 2026, indicating improving sentiment.
Bulls vs Bears: BKD Investment Factors
BKD presents a classic turnaround story with conflicting signals. Strong technical momentum and improving analyst sentiment are offset by fundamental weaknesses in profitability and leverage. The stock's value appears to hinge on its ability to translate operational scale into sustained earnings.
Bullish
- Strong Long-Term Momentum: Stock up 118.5% over past year, significantly outperforming the S&P 500.
- Positive Analyst Upgrades: Recent upgrades to 'Buy' and 'Overweight' from major banks in early 2026.
- Solid Liquidity Position: Strong current ratio of 3.62 indicates good short-term financial health.
- Attractive Price-to-Sales Ratio: P/S ratio of 0.81 suggests valuation below annual revenue.
Bearish
- Persistent Unprofitability: Negative net margin of -8.41% and consistent quarterly losses.
- High Financial Leverage: Negative debt-to-equity of -148.9 indicates significant financial strain.
- Stagnant Revenue Growth: Q4 revenue grew only 0.95% YoY, showing limited top-line expansion.
- Recent Price Weakness: Down 10.6% over past month, trading 20% below 52-week high.
BKD Technical Analysis
The stock has demonstrated strong long-term momentum, with a 118.53% gain over the past year and a 62.47% increase over the last six months, significantly outperforming the broader market. However, recent performance has been weaker, with the price declining 10.59% over the past month and trading 19.95% below its 52-week high of $17.09. The current price of $13.68 sits near the middle of its 52-week range ($4.97 to $17.09), indicating a consolidation phase after the earlier rally.
Beta
—
—
Max Drawdown
-22.6%
Largest decline past year
52-Week Range
$6-$17
Price range past year
Annual Return
+94.9%
Cumulative gain past year
| Period | BKD Return | S&P 500 |
|---|---|---|
| 1m | -8.1% | +9.1% |
| 3m | -19.5% | +6.8% |
| 6m | +37.6% | +9.9% |
| 1y | +94.9% | +30.5% |
| ytd | +19.7% | +8.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BKD Fundamental Analysis
Revenue growth has been modest, with Q4 2025 revenue of $754.1 million representing a 0.95% year-over-year increase. Profitability remains a significant challenge, as evidenced by a negative net margin of -8.41% and consistent quarterly net losses, including a loss of $39.96 million in the latest quarter. The company's financial health is strained by a high negative debt-to-equity ratio of -148.91, though it maintains a strong current ratio of 3.62 and generated positive free cash flow of $16.5 million over the trailing twelve months.
Quarterly Revenue
$754093000.0B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
-0.01%
Latest Quarter
Free Cash Flow
$16496001.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BKD Overvalued?
Given the company's negative net income, the trailing P/E ratio of -9.62 is not meaningful. A more appropriate valuation metric is the Price-to-Sales (P/S) ratio of 0.81, which suggests the market is valuing the company at less than one times its annual revenue. The EV/EBITDA ratio of 25.64 appears elevated, reflecting the market's focus on the company's operational cash flow generation potential despite its net losses. Industry average comparison data is not available.
PE
-9.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -53x~2x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.6x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is financial: BKD operates with a highly leveraged balance sheet, evidenced by a negative debt-to-equity ratio of -148.9, which could constrain strategic flexibility and amplify losses in a downturn. Operational risks include the challenge of achieving consistent profitability in a competitive senior living market with modest revenue growth (0.95% YoY in Q4) and volatile quarterly results, as seen in the swing from a gross profit of $212.8M in Q3 2025 to a gross loss of -$8.9M in Q4 2025. Market risks involve the stock's high sensitivity to sentiment, demonstrated by a 118% annual gain followed by a recent 10.6% monthly pullback, and a high short interest (short ratio of 7.05) that could lead to increased volatility. The elevated EV/EBITDA multiple of 25.6, despite net losses, suggests the market is pricing in a significant recovery, leaving the stock vulnerable to disappointment.
FAQ
The key risks are financial and operational. Financially, the company has a highly leveraged balance sheet (Debt/Equity: -148.9) which increases bankruptcy risk in a downturn. Operationally, it struggles with consistent profitability, posting a -8.4% net margin. Revenue growth is also anemic at 0.95% YoY. Additionally, the stock is volatile, with a high short ratio (7.05) and a 20% drawdown from its 52-week high, indicating sentiment-driven price swings.
The 12-month outlook is a balanced range with a base case target of $13-$16, representing modest upside from the current $13.68. The bull case ($17-$20) depends on achieving analyst EPS estimates of $0.07 and a re-rating, while the bear case ($8-$11) involves a failure to improve profitability. Analysts are cautiously optimistic, with recent upgrades, but only three provide coverage. The stock's 118% gain over the past year suggests much future growth may already be priced in.
BKD's valuation sends mixed signals. It appears undervalued on a Price-to-Sales basis (P/S ratio of 0.81), trading below its annual revenue. However, it looks overvalued on an enterprise value basis (EV/EBITDA of 25.64) given its lack of net profitability. The negative P/E ratio is not meaningful. Overall, the stock is priced for a recovery that has not yet been realized in its income statement, making it fairly valued based on current, challenged fundamentals.
BKD is a speculative buy, not a core holding. It could be suitable for investors with high risk tolerance who believe in the company's turnaround story, as suggested by recent analyst upgrades to 'Buy'. However, its persistent losses (-$40M net income in Q4), high leverage (Debt/Equity: -148.9), and volatile quarterly results make it a risky proposition. The decision should be based on conviction in its ability to achieve the estimated EPS of $0.07.
BKD is primarily a speculative, event-driven investment for the medium to long term. The short-term is likely to be volatile and driven by quarterly earnings reports and sentiment. The long-term thesis depends on a multi-year turnaround to sustainable profitability, which is uncertain. It is not suitable for short-term trading due to its high beta and volatility, nor is it a stable long-term compounder given its current financials. The ideal horizon is 1-3 years for investors monitoring its execution against profitability goals.